HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

Clairol: Procter & Gamble taps colorist/stylist Brad Johns as Clairol Global Color Director. Johns will "contribute to the creative design, research and development, and direction of the company's color and innovation work including haircolor formulations and updated shade palettes," according to P&G. Appointment is part of Clairol's effort to build a "Modern Mosaic of Color" encompassing innovations under hair color ranges like Herbal Essences and Natural Instincts, firm notes. Johns has worked with celebrities including Johnny Depp, Natasha Richardson and Matthew Modine, P&G says...

You may also be interested in...



Jaqua Opens Ivy Cottage Inn With Launch Of B&B-Inspired Body Care

Jaqua will expand its gourmand bath and body offerings with the launch of Ivy Cottage Inn B&B Collection, the company announced

Jaqua Opens Ivy Cottage Inn With Launch Of B&B-Inspired Body Care

Jaqua will expand its gourmand bath and body offerings with the launch of Ivy Cottage Inn B&B Collection, the company announced

Rodan & Fields Anti-Age Launch Backed By Sampling Campaign

The introduction of Rodan & Fields Anti-Age skin care collection will be supported by an "aggressive" sampling campaign, the Estee Lauder division said. The company will distribute 30,000 samples of a seven-day supply of the range via the brand's Web site and retail locations, according to the firm

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013152

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel